您的购物车当前为空
LSN3353871是一种高效和可口服的脂蛋白a[Lp(a)]抑制剂(IC50= 1.69 µM),能与Kringle IV(KIV)结合从而抑制 Lp(a)的形成和组装,可用于研究心血管疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
LSN3353871是一种高效和可口服的脂蛋白a[Lp(a)]抑制剂(IC50= 1.69 µM),能与Kringle IV(KIV)结合从而抑制 Lp(a)的形成和组装,可用于研究心血管疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,190 | In Stock | |
| 5 mg | ¥ 2,980 | In Stock | |
| 10 mg | ¥ 4,870 | In Stock | |
| 25 mg | ¥ 7,450 | In Stock | |
| 50 mg | ¥ 9,830 | In Stock | |
| 100 mg | ¥ 13,500 | In Stock | |
| 200 mg | ¥ 18,200 | In Stock |
| 产品描述 | LSN3353871 is a highly potent and orally available lipoprotein a [Lp(a)] inhibitor (IC50 = 1.69 µM) that binds to Kringle IV (KIV) to inhibit Lp(a) formation and assembly, making it suitable for studying cardiovascular diseases. |
| 分子量 | 255.74 |
| 分子式 | C13H18ClNO2 |
| CAS No. | 2565657-20-5 |
| Smiles | [C@@H](CC1=CC=CC=C1)(C(O)=O)[C@]2(CCNC2)[H].Cl |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 120 mg/mL (469.23 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容